Dr Lindsey Roeker: Novel Agents Have Revolutionized CLL Treatment

The introduction of novel agents has really revolutionized the care of patients with chronic lymphocytic leukemia to the point where chemotherapy is rarely used, said Lindsey Roeker, MD, clinical fellow at Memorial Sloan Kettering Cancer Center.

Read the full article here

Related Articles